Pharmacological and non-pharmacological modulation of endoplasmic reticulum stress in pediatric diabetes

Area of Science:

• Endocrinology
• Cell Biology
• Pediatric Medicine

Background:

• Endoplasmic reticulum (ER) stress is implicated in pancreatic beta-cell dysfunction and apoptosis across all pediatric diabetes types.
• ER response integrity is crucial for managing stress during insulin processing, irrespective of diabetes subtype.
• ER stress is increasingly recognized as a key contributor to diabetes pathogenesis, not just a consequence.

Purpose of the Study:

• To explore the mechanisms of ER stress in all forms of pediatric diabetes.
• To discuss therapeutic strategies for modulating ER stress, including approved pediatric medications like metformin.
• To examine combining ER stress modulation with insulin therapy for optimized beta-cell function and survival.

Main Methods:

• Literature review focusing on ER stress mechanisms in pediatric diabetes.
• Analysis of pharmacological and non-pharmacological approaches to ER stress modulation.
• Examination of therapeutic potential for beta-cell preservation.

Main Results:

• ER stress plays a significant role in pediatric diabetes pathogenesis by affecting beta-cell function and survival.
• Targeting ER stress presents a promising therapeutic avenue.
• Metformin and other approved pediatric medications show potential in modulating ER stress.

Conclusions:

• Modulating ER stress is a critical therapeutic target for pediatric diabetes.
• Combining ER stress modulation with insulin therapy may optimize metabolic homeostasis and beta-cell health.
• Further research into ER stress interventions is warranted for improved pediatric diabetes management.